This page is general health information, not medical advice. It cannot tell you whether you have an infection. A clinician can, and the testing options on this site are a good place to start.

Human papillomavirus, or HPV, is the most common sexually transmitted infection in the United States. The CDC says nearly every sexually active person who is not vaccinated will get it at some point. Most people never know, because the body usually clears it without treatment.

That is the good news. The harder part is that testing works very differently for HPV than for chlamydia or HIV. There is a routine screening plan for the cervix, and no routine HPV test for men. This guide explains why, what the research suggests about different virus types, how the vaccine works, and how to ask about screening in Houston.

HPV basics: one virus family, many types

HPV is not one virus. It is a group of more than 200 related viruses, and the CDC says about 40 of them can infect the genital area. They spread through skin-to-skin contact, including vaginal, anal and oral sex. Condoms and dental dams lower the chance of spread but do not cover all the skin involved, according to the CDC.

The CDC groups genital HPV types by what they are linked to:

Low-risk types can cause genital warts. They are not linked to cancer.
High-risk types can, in a small share of people, cause cell changes that over many years may develop into cancer.

The CDC states that HPV types 6 and 11 cause about 90 percent of genital warts. It also states that types 16 and 18 cause about 70 percent of cervical cancers. These are population figures. They do not predict what will happen in any one person.

What the virus is made of, and why that matters

The science-focused part of this topic is short, and it explains a lot about testing and the vaccine.

HPV is a small virus with a ring of DNA inside a protein shell. The shell is built mostly from a protein called L1. Two features follow from that design.

Tests look for viral DNA. Laboratory HPV tests for the cervix detect the genetic material of high-risk types in a cell sample. They do not look for antibodies, so a blood test does not serve the same purpose.
The vaccine uses the shell protein, not the virus. The CDC explains that the HPV vaccine is made from L1 protein assembled into empty particles that look like the virus. They contain no viral DNA, so they cannot cause HPV infection. Research suggests the immune system learns to recognize those particles and responds if the real virus shows up later.

HPV in women: what research and guidelines say

In women and anyone with a cervix, high-risk HPV is the main driver of cervical cell changes. The CDC notes that most infections clear on their own, typically within about two years. Cell changes tend to develop slowly when an infection does persist. That slow pace is why cervical screening is built around regular, spaced-out checks.

Cervical screening intervals from the USPSTF

The U.S. Preventive Services Task Force (USPSTF) sets the main screening schedule for people at average risk who have a cervix:

Ages 21 to 29: a Pap test (cervical cytology) every 3 years.
Ages 30 to 65: a Pap test every 3 years, an HPV test alone every 5 years, or an HPV test combined with a Pap test (called cotesting) every 5 years.
Under 21: the USPSTF recommends against screening.
Over 65: the USPSTF recommends against screening for people with adequate prior screening and who are not otherwise at high risk.
After a hysterectomy: the USPSTF recommends against screening for people who had the cervix removed and no history of a high-grade precancerous lesion or cervical cancer.

These are guidelines for people at average risk. A clinician may suggest a different plan after an abnormal result, with a weakened immune system, or with a past history of cervical changes. The USPSTF updates its guidance from time to time, so confirm the current version with a clinician.

What an abnormal result means

An abnormal Pap or a positive high-risk HPV result is a reason for follow-up, not a diagnosis of cancer. A clinician may repeat testing, look at the cervix more closely, or take a small tissue sample. Precancerous changes, when found, can be monitored or treated by a clinician. The CDC's STI Treatment Guidelines (2021) describe this follow-up pathway.

HPV in men: why there is no routine test

HPV in men is common too. Many men carry the virus without any sign of it, and most clear it, just as women do.

The CDC states that there is no approved HPV test to screen men for HPV infection, and no routine HPV test for anyone without a cervix. There are a few reasons research and guidelines point to:

Most infections clear on their own. A positive result would often reflect a passing infection, and it would not change what a clinician recommends.
No tested screening pathway exists. For the cervix, years of research show that finding and following cell changes lowers cervical cancer. The CDC states that no comparable approach has been established for the penis, mouth or throat in the general population.
The available tests were designed for cervical samples. They are not approved for use on other body sites.

This does not mean men have nothing to ask about. A clinician can examine the skin for warts, and can talk about vaccination and about any lump, sore or change a person notices.

Anal screening

The CDC's 2021 guidelines note that anal cancer screening is a topic of ongoing research. Some experts suggest anal cytology for groups with higher risk, such as people with HIV. National guidance for the general population is not established. If this applies to you, ask a clinician what they recommend.

HPV symptoms: warts, and usually nothing at all

The honest answer about HPV symptoms is that most people with HPV have none. The CDC states that HPV infections usually have no symptoms, and the person often does not know they carry it.

When there are visible signs, they depend on the type:

Genital warts from low-risk types can look like small bumps, flat patches or a cauliflower-like cluster. They can appear weeks, months or years after contact, according to the CDC.
High-risk types usually cause no symptoms in the early stage. When cervical, anal or throat cancers do cause symptoms, those tend to appear late, which is why screening for the cervix exists.

A bump or sore can have many causes, and only a clinician can say what it is. If you notice a change in your skin, in your cervical bleeding pattern, or a lump that lasts, a clinic visit is the right next step.

A related point: HPV is not on the list of infections checked in a standard panel. A basic STI panel typically covers infections such as chlamydia, gonorrhea, syphilis and HIV. Asking for "a full STD test" does not include HPV, so name it if you want to discuss it.

Treatment: what a clinician can do

The CDC states that there is no cure for the HPV virus itself, but the problems it causes can be treated. HPV is manageable, and in most people the immune system controls it over time.

Genital warts can be treated by a clinician, using either medicines applied to the skin or in-office procedures. Warts can return, and some go away without treatment.
Cervical cell changes can be monitored or treated by a clinician, depending on what is found.
HPV-related cancers are treated by specialist teams. The earlier a change is found, the more options there are, according to the CDC.

Which approach fits depends on the person, so treatment choices belong in a conversation with a clinician.

The HPV vaccine: observations and safety

Who it is recommended for

The CDC's Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination for:

All children at ages 11 or 12, and the series can be started as early as age 9.
Everyone through age 26 who was not adequately vaccinated earlier, regardless of gender.
Adults ages 27 through 45, through shared clinical decision-making. The CDC explains that benefit is smaller in this group because many people have already been exposed, so it is a conversation to have with a clinician.

The vaccine used in the United States protects against nine HPV types, including the two that cause most genital warts and the types behind most cervical cancers, according to the CDC. It is meant to prevent new infections. It does not treat an infection that is already present.

What research suggests

Research summarized by the CDC suggests that since vaccination began in 2006, infections with the types covered by the vaccine have dropped sharply in young women, and precancerous cervical changes have also fallen. Studies in several countries point the same way. These are observations from large populations, and long-term follow-up for cancer outcomes is still ongoing.

Safety profile and contraindications

The CDC states that HPV vaccine safety has been studied through monitoring systems and large studies, and that serious problems are rare. Common effects are short-lived: soreness where the shot was given, a mild fever, a headache or fainting. Fainting can follow any injection in adolescents, so clinics often ask people to sit for a short while afterward.

The CDC lists these reasons to talk with a clinician before vaccination:

A history of a severe allergic reaction to a previous HPV vaccine dose or to a component of the vaccine.
Pregnancy. The CDC says vaccination is delayed until after pregnancy, and a vaccination given during pregnancy is not a reason for alarm.
A moderate or severe illness at the time of the visit, in which case a clinician may suggest waiting.

Because the vaccine does not cover every HPV type, the CDC states that people who are vaccinated should still follow cervical screening guidelines.

Sourcing and quality indicators

For a topic like HPV, "quality" means knowing which information and which tests to trust. Some indicators worth looking for:

Sources that name their sources. Reliable health pages point to the CDC, USPSTF, state or local health departments, and say what year the guidance is from.
Tests approved for the purpose. The CDC describes HPV tests as approved for cervical samples. Be cautious about any service that offers HPV testing for men, or for the throat, as a routine screening.
A clinician who explains the result. A good visit includes what the result means, what happens next and when to come back.
No pressure to buy. Public clinics and community health centers do not need to sell you a product to give you care.
Straight answers about uncertainty. HPV science includes real gaps. A source that promises certainty about HPV is less trustworthy than one that explains what is known and what is not.

Cervical screening and HPV care in Houston

Houston has several public and community options for sexual health care. What each site offers for HPV specifically is not always published, so the most reliable step is to call and ask.

The Houston Health Department runs sexual health services at three sites: Northside Health Center, Sharpstown Health Services and the Sunnyside Health and Multi-Service Center. The department lists STD and HIV testing and treatment there, with fees on a sliding scale. Its pages do not list cervical screening or HPV vaccination, so ask when you call. The department says appointments are encouraged and walk-ins are seen as capacity permits. The appointment line for these sites is 832-393-4220. Prevention services such as PrEP are booked at 832-395-9800.

Harris County Public Health lists its Antoine Clinic at 5815 Antoine Dr, Houston, TX 77091, phone 832-927-7350, with free STI testing for HIV, syphilis, gonorrhea and chlamydia. Its page does not list HPV services, so confirm what is available before you go.

Community health centers such as Legacy Community Health also operate in Houston. Legacy's Montrose location is at 1415 California St., phone (832) 548-5100. Legacy says its services are open to all regardless of ability to pay. Ask each clinic whether it provides Pap tests, HPV tests or vaccination, and what the cost would be, since the clinics' pages do not publish those prices.

For a full list of testing sites with addresses and services, see the local testing list. For what a standard panel includes, how much it costs and how to prepare, read our guide to STD testing in Houston.

Not sure where to begin? The CDC runs a locator at gettested.cdc.gov that finds nearby testing sites by ZIP code.

Questions to bring to an appointment

Am I due for a Pap test, an HPV test or both, based on my age and history?
Is the HPV vaccine available here, and have I completed the series?
If I have a bump or sore, can you take a look?
What will this cost, and is there a sliding scale or assistance?
If a result is abnormal, what happens next and who will contact me?

Clinic staff hear these questions every day. There is no wrong way to ask.

The bottom line

HPV is common, usually silent and often cleared by the body. In women and anyone with a cervix, regular screening on the USPSTF schedule is the main safeguard. For men, there is no routine HPV test, so conversations focus on vaccination, skin checks and any changes a person notices. The vaccine is the strongest prevention tool, with a safety record that has been studied for many years.

If you have questions about your own situation, a Houston clinic can walk you through the options without judgment.

HPV in Men and Women: Testing, Vaccines and Cervical Screening in Houston